Evaluation of analytical performance in renal biochemistry laboratory using Six Sigma Metrics
Abstract
Introduction: Quality management in the healthcare system continues to be a central theme of discussion due to its direct impact on patient outcomes. Laboratory measurements inherently exhibit variability resulting from both random and systematic influences. Advances in precision medicine have increased the demand for highly accurate laboratory processes, necessitating more rigorous evaluation tools. Materials and Methods: Quality control data were collected retrospectively from July 2024 to June 2025. Six Sigma metrics were calculated for 20 biochemical parameters analyzed using the Cobas C311 system, based on the coefficient of variation (CV%), bias, and total allowable error (TAE). Results: Approximately 90% of the biochemical parameters fulfilled the Six Sigma criteria, while 10% required improvement. Discussion: Our study results for sigma metrics showed excellent performance for 8 L1 QC and 9 L2 QC parameters; very good performance for 1 L1 QC and 7 L2 QC parameters; good performance for 5 L1 QC and 1 L2 QC parameters; satisfactory/acceptable performance for 3 L1 QC and 2 L2 QC parameters; and poor sigma metrics for 3 L1 QC and 1 L2 QC parameters. Although most modern laboratories are automated, ensuring accurate and precise laboratory results remains a challenge. Conclusion: The implementation of Six Sigma metrics across laboratory processes enables the identification of errors and the introduction of innovative approaches for cost reduction without compromising quality. By systematically evaluating Six Sigma metrics, areas of strength and opportunities for improvement were clearly identified
Full Text
Tables and figures are in the full-text PDF.
Introduction
Quality management in the healthcare system continues to be a central theme of discussion, given its direct impact on patient outcomes. [1] Among various healthcare services, clinical laboratory testing plays a particularly essential role, with an estimated 70% of medical decisions relying on laboratory results. [2] The total testing process comprises three distinct phases-pre-analytical, analytical, and post-analytical-each contributing differently to overall laboratory error rates. Reported error frequencies range from 30-75% in the preanalytical phase, 4-30% in the analytical phase, and 9-55% in the post-analytical phase. [3] These figures highlight the critical need for robust quality control practices to ensure the reliability of test results and to enhance patient care. Laboratory measurements inherently exhibit variability due to random and systematic influences. [4,6] Bias, defined as the systematic deviation of a test result from the true value, can significantly affect diagnostic accuracy, prognosis estimation, and healthcare costs. [7][8][9] Quality in laboratory medicine is therefore defined as conformance to user requirements, [10] forming the basis for analytical accuracy and precision. Quality control (QC) practices are traditionally divided into external quality assessment (EQA) and internal quality control (IQC). [11] While EQA provides periodic evaluation through comparison with external reference laboratories, IQC ensures continuous monitoring of analytical performance. Together, these systems help maintain result reliability prior to report release. Advances in precision medicine have increased the demand for highly accurate laboratory processes, necessitating more rigorous evaluation tools. This has brought increasing attention to the Six Sigma management methodology as a means to reduce errors, enhance process capability, and support continuous improvement. [12] Originally developed by Bill Smith at Motorola and later introduced in China in the late 1990s, Six Sigma principles began finding application in healthcare management after 1991. [13] Six Sigma employs a structured framework consisting of five stages: Define, Measure, Analyze, Improve, and Control (DMAIC). Mathematically, sigma represents standard deviation, reflecting the degree of variation in a process. [14] Six Sigma metrics quantify errors in terms of defects per million opportunities (DPMO) and provide a standardized scale for assessing process performance. [15] As an evolution of Total Quality Management (TQM), sigma metrics offer a more objective and quantitative method to identify errors, evaluate analytical quality, and guide process optimization within clinical laboratories. [14] The corresponding sigma levels and expected defects per million (DPM) tests are summarized below: Given the high diagnostic value of renal biochemical testing and the need for optimal analytical performance, the present study was undertaken to assess quality system processes in a Renal Biochemistry Laboratory using Six Sigma metrics and to implement corrective actions aimed at improving analytical quality. Aim: To retrospectively evaluate and analyze the quality control (QC) procedures in a Renal biochemistry laboratory and to implement corrective measures to improve analytical performance using the Six Sigma scale.
Materials and Methods
This retrospective study was conducted in the accredited Shankara Laboratories Abhiramapuram, Chennai, Tamil Nadu, India. Internal Quality Control (IQC) and External Quality Assurance Scheme (EQAS) data from July 2024 to June 2025 were analyzed for 20 Biochemical parameters.
As per the laboratory's QC policy, two levels of controls were used: Level 1 (normal) and Level 2 (abnormal). Biochemical parameters were analyzed on the Cobas C311 system using Bio-Rad control QC materials. Levy-Jennings charts were verified for QC deviations. Corrective actions, if required, were taken prior to processing patient samples and releasing reports.
Six Sigma Metrics
The Six Sigma metrics for each parameter were calculated using imprecision (CV%), bias, total allowable error (TAE) and Quality Index Goal (QGI) as described below:
Coefficient of Variation (CV%)
Bias was determined from monthly EQAS results provided by Bio-Rad peer group data:
Total Allowable Error (TAE) TAE incorporates both imprecision and bias (trueness) to assess the acceptability of a test method. TAE values were obtained from the Clinical Laboratory Improvement Amendments (CLIA) 2025 proficiency testing criteria (16).
For parameters not listed in CLIA, equivalent data from the Royal College of Pathologists of Australasia (RCPA) guidelines were used.
Six Sigma Calculation
The sigma metrics were calculated using the following formula:
Discussion
Our study results for sigma metrics showed excellent performance for 8 L1 QC and 9 L2 QC parameters, very good performance for 1 L1 QC and 7 L2 QC parameters, good performance for 5 L1 QC and 1 L2 QC parameters, satisfactory/acceptable performance for 3 L1 QC and 2 L2 QC parameters, and poor sigma metrics for 3 L1 QC and 1 L2 QC parameters (Table 8).
In our study, we evaluated the analytical performance of 20 frequently requested renal biochemical parameters. Among these, five parameters-Alkaline Phosphatase (ALP), Bilirubin Total, High-Density Lipoprotein Cholesterol (HDL), Cholesterol, and Uric Acid-showed excellent performance for both L1 and L2 QCs. Seven parameters, namely Bilirubin Direct, Low-Density Lipoprotein Cholesterol (LDL), Iron, Triglycerides (TGL), Magnesium, Phosphorus, and Gamma-Glutamyl Transferase (GGT), showed excellent performance for one level of QC. Five parameters-Albumin, Creatinine (Jaffe), Glucose, Total Protein, and Urea-exhibited satisfactory/acceptable performance for both levels of QC. Aspartate Transaminase (AST), Alanine Transaminase (ALT), and Calcium showed poor sigma metrics (<3), with AST and ALT poor at one QC level and Calcium poor at both QC levels. (Fig. 1)
We performed root cause analysis and calculated the Quality Goal Index (QGI) for these three poor-performing parameters. QGI indicated inaccuracy for both AST and ALT (requiring focus on EQAS). For Calcium, we observed both inaccuracy and imprecision (requiring focus on EQAS and IQC). The inaccuracy for AST and ALT was likely due to bias deviation during August 2024 caused by random error. For Calcium, we decided to strengthen IQC and calibration frequency, and also to explore alternative methodologies such as ionized calcium. Although most modern laboratories are automated, ensuring accurate and precise laboratory results remains a challenge [17] . Although IQC provides continuous monitoring of analytical methods, the exact number of errors occurring during the analytical phase cannot be fully evaluated [18] . The analytical phase is particularly crucial, as it involves personnel, instruments, and methodologies. Method validation studies, the application of QC sampling procedures, and frequent training programs have considerably reduced analytical errors [19,20] Six Sigma metrics integrate both internal and external quality control performance; both components are essential tools for evaluating the quality and stability of the analytical system. The application of Six Sigma metrics is necessary to minimize variance and enhance QC processes, thereby improving compliance with vital quality requirements. Sigma metrics also help assess the use of superior analytical methods to improve overall laboratory performance. Numerous studies have reported six sigma performance in biochemical parameters, summarized in Table 9. Details of various Indian studies on six sigma metrics shown in table 6, Study 1 Singh B et. al [21] , Study 2 Nanda SK et al (11), Study 3 Chaudhary NG et al [22] , Study 4 Chauhan KPC et al [23] , Study 5 Kumar BV et al [24] , Study 6 Lakshnam M et al [25] , Study 7 Suresh Babu Ganji et al [26] .
A major strength of this study is its 12-month duration, which provided a robust reflection of the data, as accuracy and imprecision estimates improve with larger datasets [27] Additionally, third-party QC materials were used. It is recommended that, whenever possible, third-party QC materials be used rather than manufacturer-supplied control materials. When QC materials differ from calibrator materials, they provide an independent and unbiased assessment of the measurement procedure's performance [28] , overall 90% of routine renal biochemistry parameters fulfilled six sigma metrics and 10% required improvement.
Conclusion
Physicians increasingly rely on laboratory-generated information for disease diagnosis, patient monitoring, treatment planning, and evaluation of treatment effectiveness. Laboratories should therefore aim to minimize errors that can negatively affect patient outcomes. The implementation of Six Sigma metrics across laboratory processes enables the identification of errors and the introduction of innovative approaches for cost reduction without compromising quality. By systematically evaluating Six Sigma metrics, areas of strength and opportunities for improvement were clearly identified. This approach not only highlighted the reliability of well-performing assays but also provided a structured framework for corrective action in parameters falling below desirable Sigma metric levels. The Sigma metrics tool has the potential to be a valuable quality-management instrument for monitoring analytical performance in comparison with world-class standards. Overall, Sigma metrics serves as a valuable tool in clinical laboratories, supporting error reduction, process optimization, and continuous improvement to ensure high standards of patient care and diagnostic reliability
References
- Shah S, Saini R, Singh SB, Aggarwal O, Goel AK. Six Sigma Metrics and Quality control in Clinical Laboratory. Int J Med Res Rev. 2014;2(2):123-130.
- Forsman RW. Why is the laboratory an afterthought for managed care organization. Clin Chem. 1996;42:813816.
- Bononi P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem. 2002;48(5):691-698.
- Fraser CG. Biological variation: From principles to practice. Washington, DC: AACC Press; 2001.
- Frenkel R, Farrance I, Badrick T. Bias in analytical chemistry: A review of selected procedures for incorporating uncorrected bias into the expanded uncertainty of analytical measurements and graphical method for evaluating the concordance of reference and test procedures. Clin Chim Acta. 2019;495:129-138. DOI:10.1016/j.cca.2019.03.163.
- Nielsen AA, Petersen PH, Green A, Christensen C, Christensen H, Brandslund I. Changing from glucose to HbA1c for diabetes diagnosis: Predictive values of one test and importance of analytical bias and imprecision. Clin Chem Lab Med. 2014;52:1069-1077. DOI:10.1515/cclm-2013-0337.
- Weykamp C, John G, Gillery P, English E, Ji L, Lenters-Westra E, et al. Investigation of 2 models to set and evaluate quality targets for HbA1c: Biological variation and sigma metrics. Clin Chem. 2015;61:752759. DOI:10.1373/clinchem.2014.235333.
- Mower WR. Evaluating bias and variability in diagnostic test reports. Ann Emerg Med. 1999;33:385391. DOI:10.1016/S0196-0644(99)70422-1.
- Burtis AC, Ashwood ER, Bruns DE. Tietz Fundamentals of Clinical Chemistry. 6th ed. St. Louis: Elsevier; 2008.
- Nanda SK, Ray L. Quantitative application of sigma metrics in medical biochemistry. Clin Diagn Res. 2013;7(12):2689-2691.
- Zhou B, Wu Y, He H, Li C, Tan L, Cao Y. Practical application of Six Sigma management in analytical biochemistry processes in clinical settings. Clin Lab Anal. 2020;34:e23126. DOI:10.1002/jcla.23126.
- Cano EL, Moguerza JM, Redchuk A. Six Sigma with R: Statistical Engineering for Process Improvement. New York, NY: Springer Science + Business Media; 2012.
- Nevalainen D, Berte L, Kraft C, Leigh E, Picaso L, Morgan T. Evaluating laboratory performance on quality indicators with the six sigma scale. Arch Pathol Lab Med. 2000;124:516-519.
- Vinodh Kumar B, Thuthi M. Sigma metrics in evaluating the performance of clinical chemistry laboratory. J Lab Physicians. 2018;10(2):100-105.
- CLIA. 2025 CLIA Acceptance limits for Proficiency Testing. [Internet]. 2025.
- Abdollahi A, Saffer H. Types and frequency of errors during different phases of testing at a clinical medical laboratory of a teaching hospital in Tehran, Iran. N Am J Med Sci. 2014;6(5):224-230. DOI:10.4103/19472714.132941.
- Sayeed S, Ganji SB, Mopuri R. A short-term assessment of routine chemistry parameters by sigma metrics and quality goal index ratio in a tertiary care hospital laboratory. J Evol Med Dent Sci. 2019;8(29):2303-2306. DOI:10.4260/jemds/2019/505.
- Henry RJ, Segalore M. The running of standards in clinical chemistry and the use of control chart. J Clin Pathol. 1952;4:305-311.
- Levy S, Jennings ER. The use of control charts in the clinical laboratory. Am J Clin Pathol. 1950;20(11):1059-1066.
- Singh B, Goswami B, Gupta VK, Chawala R, Mallika V. Application of sigma metrics for the assessment of quality assurance in clinical biochemistry laboratory in India: a pilot study. Indian Clin Biochem. 2011;26(2):131-135.
- Chaudhary NG, Patani SS, Sharma H, Maheswari A, Jadhav PM, Maniar MA. Application of six sigma for quality assurance in clinical biochemistry laboratory -a retrospective study. Int J Res Med. 2013;2(3):17-20.
- Chauhan KPC, Patel JD, Trivedi A. Six sigma in clinical biochemistry; it matters, measure it. Int J Clin Biochem Res. 2017;4(3):270-274.
- Kumar BV, Mohan T. Sigma metrics as a tool for evaluating performance of internal quality control in a clinical chemistry laboratory. J Lab Physicians. 2018;10:194-199.
- Lakshman MR, Bhulaxmi P, Malathi K, Salma M, Prakasham S. Evaluation of sigma metrics in a medical biochemistry lab. Int J Biomed Res. 2015;6(3):164-171.
- Gangi SB, Revupalli S. Evaluation of Quality Assurance in a new clinical chemistry laboratory by Six Sigma metrics. J Clin Diagn Res. 2019;13(12):OC26OC30. DOI:10.7860/JCDR/2019/40568.12666.
- Jones G, Calleja J, Chesher D, et al. Collective opinion paper on a 2013 AACB workshop of experts seeking harmonization of approaches to setting a laboratory quality control policy. Clin Biochem Rev. 2015;36(3):87-95.
- CLSI. Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions. 4th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
How this paper connects to the literature. Drag to explore, click any node to open that paper.
